Drug Trial Radar · NCT04689100
Efficacy and Safety of JMT101 in Patients With Advanced Solid Tumor
Last checked: Nov 19, 2026Latest source record: Dec 30, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
259
Planned (sponsor's estimate)
Start
Apr 11, 2017
Primary completion
Dec 31, 2021
Study completion Jun 30, 2022
Sponsor
- Lead sponsor
- Shanghai JMT-Bio Inc.Industry
- Sponsor type
- Industry
- Collaborators
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- First posted
- Dec 30, 2020
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a Phase I, open label, multi-center study of to evaluate the safety and efficacy of JMT101 in patients with advanced solid tumor.
Conditions
- Advanced Solid Tumor
Interventions
JMT101Drug
Monotherapy: Accelerated titration method, IV infusion QW; Conventional 3 + 3 study design, IV infusion Q2W. (28-day cycles) Combined with chemotherapy: Conventional 3 + 3 study design, IV infusion Q2W. (28-day cycles)
JMT101Drug
IV infusion Q2W (28-day cycles)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of adverse events (defined by the Common Terminology Criteria for Adverse Events version 4.03 (CTCAE V4.03)).Time frame: From enrollment until 30 days after the last dose
- Number of Subjects Experiencing DLTs (Dose Limiting Toxicity).Time frame: Time from the first dose of study drug up to 4 weeks
- Maximum Tolerated Dose (MTD)Time frame: 28 days
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
Beijing Luhe Hospital. Capital Medical University
Beijing, China · Recruiting
Peking University Cancer Hospital
Beijing, China · Recruiting
The first affiliated hospital of bengbu medical college
Bengbu, China · Recruiting
The First People's Hospital of Changzhou
Changzhou, China · Recruiting
Chongqing University Cancer Hospital
Chongqing, China · Recruiting
The Sixth Affiliated Hospital, Sun Yat-sen University
Guangzhou, China · Recruiting
Zhongshan Hospital
Shanghai, China · Recruiting
The First Affiliated Hospital of Soochow University
Suzhou, China · Recruiting
Henan Cancer Hospital
Zhengzhou, China · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.